Loading company…
NeuroClin conducts research studies on Alzheimer's disease, dementia, Parkinson's disease, depression, and other neurological conditions.
NeuroClin conducts research studies and clinical trials on Alzheimer's disease, dementia, Parkinson's disease, depression, and related conditions, including studies of approved treatments such as Aricept and Exelon. Founded in 2003 by Fraser Inglis, it is based in Glasgow, UK. N4 Partners invested in the company in January 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in